These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4373869)

  • 1. Contact activation of heparinized plasma.
    Caprini JA; Eckenhoff JB; Ramstack JM; Zuckerman L; Mockros LF
    Thromb Res; 1974 Sep; 5(3):379-400. PubMed ID: 4373869
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change in plasma esterase activity during stimulation of the "2d anticoagulation system"].
    Baskova IP; Cherkesova DU; Orlova AS; Kudriashov BA
    Vopr Med Khim; 1974; 20(5):482-9. PubMed ID: 4456798
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of adrenaline on the contact phase of blood coagulation].
    Ratmanova VI
    Fiziol Zh SSSR Im I M Sechenova; 1976 May; 62(5):699-702. PubMed ID: 1278548
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
    Nielsen VG; Cohen BM; Cohen E
    Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New evidence for the activation of factor XII by epinephrine.
    Zubairov DM; Popova LG
    Thromb Res; 1976 May; 8(5):587-97. PubMed ID: 180627
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive inactivation of factor VII in the cold by heparin.
    Godal HC; Gravem K; Laake K
    Thromb Res; 1974 May; 4(5):707-11. PubMed ID: 4838250
    [No Abstract]   [Full Text] [Related]  

  • 7. The contact phase of coagulation in the presence of heparin.
    BLOOM AL
    J Clin Pathol; 1962 Nov; 15(6):508-10. PubMed ID: 13971779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective esterase and kinin-forming activity in human Fletcher trait plasma. A fraction rich in kallikreinlike activity.
    Donaldson VH; Saito H; Ratnoff OD
    Circ Res; 1974 May; 34(5):652-62. PubMed ID: 4545268
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials.
    Rhodes NP; Williams DF
    Biomaterials; 1994 Jan; 15(1):35-7. PubMed ID: 8161655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma.
    Saito H; Ratnoff OD; Donaldson VH
    Circ Res; 1974 May; 34(5):641-51. PubMed ID: 4826936
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of lysozyme suppression of factor XII activation on postadrenaline hypercoagulation].
    Zubairov DM; Ratmanova VI
    Fiziol Zh SSSR Im I M Sechenova; 1980 Feb; 66(2):177-80. PubMed ID: 7364117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant activities of heparin and fragments.
    Barrowcliffe TW; Thomas DP
    Ann N Y Acad Sci; 1989; 556():132-45. PubMed ID: 2660683
    [No Abstract]   [Full Text] [Related]  

  • 14. Further purification and properties of Hageman factor cofactor.
    Herbert RJ; Ogston D; Douglas AS
    Biochim Biophys Acta; 1972 Jul; 271(2):371-7. PubMed ID: 4340028
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stability of the anticoagulating effect of calcium and sodium heparin, injected subcutaneously].
    Langer B; Pinto WC; Maia RA; Kwang WT; Leão LE
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):121-3. PubMed ID: 308244
    [No Abstract]   [Full Text] [Related]  

  • 16. Measuring the degree of plasma contact activation induced by artificial materials.
    Sánchez J; Lundquist PB; Elgue G; Larsson R; Olsson P
    Thromb Res; 2002 Mar; 105(5):407-12. PubMed ID: 12062542
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin release is insufficient in syringes with platelets as heparin source.
    Gruber M; Spaeth R; Bechmann V
    Clin Chim Acta; 2008 Sep; 395(1-2):187. PubMed ID: 18515082
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemorheological studies of the effect of heparin on the course of coagulation.
    Overholser KA; Baysinger CB; Harris TR; Deveau T
    Thromb Haemost; 1976 Apr; 35(2):447-59. PubMed ID: 989642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activation of the contact activation system (Hageman factor system) in plasma by acidic phospholipids and the inhibitory effect of beta 2-glycoprotein I on this activation.
    Schousboe I
    Int J Biochem; 1988; 20(3):309-15. PubMed ID: 3356294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact product in experimental intravascular activation of the clotting system.
    Altman R; Rouvier J; Daldin J
    Rev Bras Pesqui Med Biol; 1973; 6(5):223-8. PubMed ID: 4774622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.